Enanta Pharmaceuticals Inc (OQ:ENTA)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for ENTA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 29th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 8/24 Mar 6/24 Vance Terry Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Russell Lesley Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Peterson Kristine Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Hata Yujiro S Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Foletta Mark G Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Carter Bruce L A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Feb 27/24 Feb 26/24 Gardiner Nathaniel S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,187  
Feb 27/24 Feb 26/24 Gardiner Nathaniel S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,187 $8.99
Feb 14/24 Feb 12/24 Luu Brendan Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -973 $12.41
Feb 14/24 Feb 12/24 Luu Brendan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,320  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ENTA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 29th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 8/24 Mar 6/24 Vance Terry Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Russell Lesley Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Peterson Kristine Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Hata Yujiro S Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Foletta Mark G Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Mar 8/24 Mar 6/24 Carter Bruce L A Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 15,700  
Feb 27/24 Feb 26/24 Gardiner Nathaniel S. Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,187  
Feb 27/24 Feb 26/24 Gardiner Nathaniel S. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,187 $8.99
Feb 14/24 Feb 12/24 Luu Brendan Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -973 $12.41
Feb 14/24 Feb 12/24 Luu Brendan Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,320  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ENTA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.